IBM®
Skip to main content
    Country/region [select]      Terms of use
 
 
   
     Home      Products      Services & solutions      Support & downloads      My account     

 

Notes to consolidated financial statements (audited)

International Business Machines Corporation and Subsidiary Companies

previous  |  next

 A. Significant accounting policies
B. Accounting changes
C. Acquisitions/divestitures
D. Financial instruments (excluding derivatives)
E. Inventories
F. Financing receivables
G. Plant, rental machines and other property
H. Investments and sundry assets
I. Intangible assets including goodwill
J. Securitization of receivables
K. Borrowings
L. Derivatives and hedging transactions
 
 M. Other liabilities
N. Stockholders’ equity activity
O. Contingencies and commitments
P. Taxes
Q. Research, development and engineering
R. 2005 actions
S. Earnings per share of common stock
T. Rental expense and lease commitments
U. Stock-based compensation
V. Retirement-related benefits
W. Segment information
X. Subsequent events

Q. Research, development and engineering (audited)

RD&E expense was $5,842 million in 2005, $5,874 million in 2004 and $5,314 million in 2003.

The company incurred expense of $5,379 million in 2005, $5,339 million in 2004 and $4,814 million in 2003 for scientific research and the application of scientific advances to the development of new and improved products and their uses as well as services and their application. Of these amounts, software-related expense was $2,689 million, $2,626 million and $2,393 million in 2005, 2004 and 2003, respectively. Included in the expense was a charge of $1 million and $9 million in 2005 and 2003, respectively, for acquired in-process R&D.

Expense for product-related engineering was $463 million, $535 million and $500 million in 2005, 2004 and 2003, respectively.

previous  |  next
Back to top
Download: Report of financials (1.9MB)
Download: IBM Annual Report 2005 (2.9MB)
Get Adobe® Reader®
   
 



    About IBMPrivacyContact